Shares of Teladoc Health Inc (NYSE:TDOC) dropped 6.3% during mid-day trading on Monday . The company traded as low as $77.37 and last traded at $78.44, approximately 1,947,352 shares were traded during mid-day trading. An increase of 44% from the average daily volume of 1,349,101 shares. The stock had previously closed at $83.74.
TDOC has been the topic of a number of analyst reports. ValuEngine raised Teladoc Health from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, October 22nd. Royal Bank of Canada initiated coverage on Teladoc Health in a research report on Wednesday, November 27th. They issued an “outperform” rating and a $100.00 price target on the stock. Piper Jaffray Companies set a $87.00 price target on Teladoc Health and gave the company a “buy” rating in a research report on Friday, August 16th. Deutsche Bank initiated coverage on Teladoc Health in a research report on Thursday, September 12th. They issued a “buy” rating and a $76.00 price target on the stock. Finally, Zacks Investment Research lowered Teladoc Health from a “buy” rating to a “hold” rating and set a $89.00 price target on the stock. in a research report on Wednesday, November 27th. Four investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $81.73.
The firm has a market cap of $6.06 billion, a PE ratio of -54.47 and a beta of 1.40. The company has a current ratio of 6.55, a quick ratio of 6.55 and a debt-to-equity ratio of 0.44. The business has a fifty day moving average price of $75.77 and a 200 day moving average price of $66.84.
Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.28) EPS for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.12. Teladoc Health had a negative return on equity of 11.23% and a negative net margin of 20.15%. The business had revenue of $137.96 million for the quarter, compared to the consensus estimate of $136.46 million. During the same quarter in the prior year, the business posted ($0.34) EPS. The business’s revenue for the quarter was up 24.3% on a year-over-year basis. On average, research analysts expect that Teladoc Health Inc will post -1.55 earnings per share for the current fiscal year.
In related news, SVP Andrew Turitz sold 9,158 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $62.27, for a total transaction of $570,268.66. Following the transaction, the senior vice president now owns 6,827 shares in the company, valued at approximately $425,117.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Adam C. Vandervoort sold 3,525 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $79.12, for a total value of $278,898.00. Following the transaction, the insider now owns 1,114 shares in the company, valued at approximately $88,139.68. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,582 shares of company stock worth $5,614,983. Company insiders own 3.14% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in TDOC. Marshall Wace North America L.P. purchased a new position in Teladoc Health during the 1st quarter worth approximately $35,000. Cornerstone Advisors Inc. grew its stake in Teladoc Health by 187.0% during the 2nd quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock worth $31,000 after buying an additional 303 shares during the last quarter. Commonwealth Equity Services LLC grew its stake in Teladoc Health by 9.0% during the 2nd quarter. Commonwealth Equity Services LLC now owns 31,143 shares of the health services provider’s stock worth $2,068,000 after buying an additional 2,563 shares during the last quarter. Westside Investment Management Inc. purchased a new position in Teladoc Health during the 2nd quarter worth approximately $26,000. Finally, Artemis Investment Management LLP grew its stake in Teladoc Health by 4.9% during the 2nd quarter. Artemis Investment Management LLP now owns 151,900 shares of the health services provider’s stock worth $9,800,000 after buying an additional 7,147 shares during the last quarter.
About Teladoc Health (NYSE:TDOC)
Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.